January 2020 Issue Table Of Contents

From The Editor

• Can You Help With Gender Diversity In The New Year?

Feature Articles

• The 5-Step Strategy That Saved Genmab From A Dire Outlook
• J&J And Merck Detail How They Are Investing For Impact

Capitol Perspectives

• The Risks Of Restructuring Part D

From Principles and Policy to Execution

• Healthcare 2.0 Requires Convergence Of  Hindsight With 2020 Foresight

Companies To Watch

• Scynexis

Patient Perspectives

• Finding Hope In A Bioelectronic Medical Clinical Trial

Industry Research

• Stances On Implementing Virtual Trials

Inside The Industry

• Women On Boards: How We Get From Here To There
• How We Landed In The International Space Station
• Using Competitive Intelligence To Reduce Competitive Risks
• IP Due Diligence Checklist: What To Address Before Executing A Transaction
• A Small Biopharma That Doesn’t Use CROs
• How Biopharma Leaders Can Ward Off A Perfect Storm: Part 2
• How A Real Estate Strategy Can Fuel A Biopharma’s Growth
• How To Overcome The Challenge Of Valuing A Biotech

Leadership Lessons

• To Succeed In An AI World, Focus On Your Human Qualities

Ask The Board

• When You Have Investors/VCs On Your Board, How Do You Help Them Keep Their Director Hat On Vs. Their Investor Hat When Making Decisions?
• The Overall Complexity Of Biopharma Operations Is Increasing. How Do You Strategize To Meet Current And Future Needs In The Most Efficient (e.g., Cost) Manner Possible?
• Have You Had To Retire Or Remove A Director From Your Board? If So, How Did You Approach It?